Skip to main content
Premium Trial:

Request an Annual Quote

EMD Millipore to Distribute Firefly BioWorks' microRNA Profiling Assay

NEW YORK (GenomeWeb News) – EMD Millipore, a division of Germany's Merck KGaA, announced this week that it has signed a deal to become the global distributor of Firefly BioWorks' SmartRNAplex microRNA profiling assay.

Specific terms of the deal were not disclosed.

According to EMD Millipore, the assay involves the hybridization of miRNA targets to probes attached to Firefly's proprietary hydrogel particles. A universal biotinylated adapter is then ligated to the captured targets, and a fluorescent reporter binds to the universal adapter. The reporter is used for miRNA detection in a flow cytometer.

"As microRNA-based research evolves from discovery to validation, robust, multiplex methods that can be performed easily at the bench are necessary to continue advancements in the field," Grace Johnston, marketing manager for EMD Millipore, said in a statement. "The SmartRNAplex assay is an important new tool for our customers who are elucidating the role of microRNAs in a broad range of human diseases and need to explore multiple targets across many samples."

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more